|
2025-06-16 |
2025-06-13 |
VP
Vente planifiée
|
Rodman David Malcom
Chief Medical Officer
Dirigeant
|
1 000
-10.1%
14,60
165 931 USD
|
1 000
-10.1%
|
14,60
|
100 000 USD
|
|
|
2025-05-15 |
2025-05-14 |
VP
Vente planifiée
|
Rodman David Malcom
Chief Medical Officer
Dirigeant
|
11 366
-9.6%
15,29
173 774 USD
|
11 366
-9.6%
|
15,29
|
173 774 USD
|
|
|
2025-04-15 |
2025-04-14 |
VP
Vente planifiée
|
Rodman David Malcom
Chief Medical Officer
Dirigeant
|
8 400
-7.0%
14,83
124 572 USD
|
8 400
-7.0%
|
14,83
|
124 572 USD
|
|
|
2025-04-15 |
2025-04-14 |
VP
Vente planifiée
|
Rodman David Malcom
Chief Medical Officer
Dirigeant
|
2 966
-2.4%
13,69
40 613 USD
|
2 966
-2.4%
|
13,69
|
40 613 USD
|
|
|
2025-04-15 |
2025-04-11 |
VP
Vente planifiée
|
Congleton Jon
Chief Executive Officer
Administrateur exécutif
|
15 319
-1.7%
12,19
186 803 USD
|
15 319
-1.7%
|
12,19
|
186 803 USD
|
|
|
2025-04-15 |
2025-04-11 |
VP
Vente planifiée
|
Levy Adam Scott
CFO and Secretary
Dirigeant
|
10 757
-4.8%
12,06
129 684 USD
|
10 757
-4.8%
|
12,06
|
129 684 USD
|
|
|
2025-04-03 |
2025-04-01 |
VP
Vente planifiée
|
Rodman David Malcom
Chief Medical Officer
Dirigeant
|
22 406
-16.1%
16,77
375 749 USD
|
22 406
-16.1%
|
16,77
|
375 749 USD
|
|
|
2025-04-03 |
2025-04-01 |
VP
Vente planifiée
|
Rodman David Malcom
Chief Medical Officer
Dirigeant
|
2 791
-2.0%
16,02
44 717 USD
|
2 791
-2.0%
|
16,02
|
44 717 USD
|
|
|
2025-04-03 |
2025-04-01 |
VP
Vente planifiée
|
Rodman David Malcom
Chief Medical Officer
Dirigeant
|
30 574
-17.7%
15,00
458 543 USD
|
30 574
-17.7%
|
15,00
|
458 543 USD
|
|
|
2025-04-25 |
2025-03-13 |
A
Achat
|
Slingsby Brian Taylor
Administrateur non-exécutif
Actionnaire important
|
259 259
+3.0%
13,50
3 499 997 USD
|
259 259
+3.0%
|
13,50
|
3 499 997 USD
|
|
|
2025-03-17 |
2025-03-13 |
A
Achat
|
Samsara BioCapital GP, LLC
Actionnaire important
|
600 000
+11.8%
13,50
8 100 000 USD
|
600 000
+11.8%
|
13,50
|
8 100 000 USD
|
|
|
2025-03-17 |
2025-03-13 |
A
Achat
|
AKKARAJU SRINIVAS
Administrateur non-exécutif
|
600 000
+11.8%
13,50
8 100 000 USD
|
600 000
+11.8%
|
13,50
|
8 100 000 USD
|
|
|
2025-03-17 |
2025-03-13 |
A
Achat
|
RA CAPITAL MANAGEMENT, L.P.
Administrateur non-exécutif
|
1 296 296
+43.4%
13,50
17 499 996 USD
|
1 296 296
+43.4%
|
13,50
|
17 499 996 USD
|
|
|
2025-01-15 |
2025-01-13 |
VP
Vente planifiée
|
Congleton Jon
Chief Executive Officer
Administrateur exécutif
|
18 333
-2.0%
9,06
166 082 USD
|
18 333
-2.0%
|
9,06
|
166 082 USD
|
|
|
2025-01-15 |
2025-01-13 |
VP
Vente planifiée
|
Levy Adam Scott
CFO and Secretary
Dirigeant
|
100
-0.0%
9,63
963 USD
|
100
-0.0%
|
9,63
|
963 USD
|
|
|
2025-01-15 |
2025-01-13 |
VP
Vente planifiée
|
Levy Adam Scott
CFO and Secretary
Dirigeant
|
10 657
-4.5%
9,09
96 901 USD
|
10 657
-4.5%
|
9,09
|
96 901 USD
|
|
|
2024-11-12 |
2024-11-11 |
VP
Vente planifiée
|
Rodman David Malcom
Chief Medical Officer
Dirigeant
|
5 026
-3.4%
15,00
75 398 USD
|
5 026
-3.4%
|
15,00
|
75 398 USD
|
|
|
2024-11-08 |
2024-11-06 |
VP
Vente planifiée
|
Rodman David Malcom
Chief Medical Officer
Dirigeant
|
25 482
-15.8%
15,03
383 066 USD
|
25 482
-15.8%
|
15,03
|
383 066 USD
|
|
|
2024-10-15 |
2024-10-11 |
VP
Vente planifiée
|
Levy Adam Scott
CFO and Secretary
Dirigeant
|
10 757
-4.3%
13,57
146 004 USD
|
10 757
-4.3%
|
13,57
|
146 004 USD
|
|
|
2024-10-15 |
2024-10-11 |
VP
Vente planifiée
|
Congleton Jon
Chief Executive Officer
Administrateur exécutif
|
15 271
-1.7%
13,52
206 433 USD
|
15 271
-1.7%
|
13,52
|
206 433 USD
|
|
